Generated by AI
Intelligent Bio Solutions Inc. is a medical technology company focused on delivering rapid, non-invasive testing and screening solutions. The company’s current offerings center on the Intelligent Fingerprinting platform, which uses fingerprint sweat analysis with a portable handheld reader and single-use cartridge to support drug screening in workplace and other safety-critical settings. It also develops a biosensor platform aimed at diagnostic and monitoring applications, including clinical chemistry, immunology, hormones, tumor markers, and nucleic acid testing. Intelligent Bio Solutions serves customers across the United States, the United Kingdom, Asia Pacific, and other international markets, positioning itself in the broader medical diagnostics and life sciences sector. Headquartered in New York, the company concentrates on tools that combine portability, speed, and non-invasive sample collection for practical use in professional testing environments.
Website135 West, 41st Street
New York, NY, 10036
United States
The latest articles about INBS.
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions (NASDAQ:INBS)
Summary of Sep 1's posts. Generated by AI.
Summary of Feb 5's posts. Generated by AI.
Summary of Dec 31's posts. Generated by AI.
Summary of Sep 1's posts. Generated by AI.
Investors talking about INBS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.